Rebinyn 500 Unit (Coagulation Factor Ix (Recombinant), Pegylated POWDER FOR SOLUTION) 500 UNIT

REBINYN 500 Unit is a recombinant coagulation factor IX therapy used for hemophilia B management. This powder for solution is designed for intravenous administration, offering a convenient treatment option.

Strength

500 UNIT

Pack Size

500 IU VIAL

Manufacturer / TM Owner

NOVO NORDISK CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

REBINYN 500 Unit is primarily used for the control and prevention of bleeding episodes in patients with hemophilia B, a condition characterized by a deficiency in coagulation factor IX. This medication is formulated to help manage bleeding episodes and can be used on-demand or as part of a routine treatment plan. Patients often ask, 'What is REBINYN used for?'—it is specifically indicated for hemophilia B, providing essential clotting factors to support normal blood coagulation.

Side Effects

Common effects of REBINYN 500 Unit may include localized reactions at the injection site, such as redness or swelling. Some users might experience mild to moderate discomfort during administration. These effects are generally temporary and should be monitored. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

REBINYN 500 Unit should be handled with care, ensuring proper storage and preparation. It is crucial to follow the prescribed guidelines for administration to minimize the risk of adverse reactions. Patients with known allergies to any components of the medication should exercise caution. Always use under medical supervision.

Avoid Interactions

REBINYN 500 Unit may interact with other medications, particularly those that affect blood clotting. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also influence the effectiveness of this medication.

Frequently Asked Questions

REBINYN is used for the control and prevention of bleeding episodes in patients with hemophilia B.

REBINYN is administered intravenously after reconstituting the powder with the provided solution.

Common side effects may include localized reactions at the injection site, such as redness or swelling.

REBINYN is specifically indicated for hemophilia B and should not be used for other bleeding disorders without medical advice.

REBINYN should be stored as per the manufacturer's instructions to maintain its effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.